Literature DB >> 9162206

Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data.

H Ben-Aryeh1, T Jungerman, R Szargel, E Klein, D Laufer.   

Abstract

The extent of hypersalivation was evaluated in a group of 25 schizophrenic patients on clozapine. A high prevalence of the complaint was detected by a questionnaire; up to 80% of the patients complained of hypersalivation at night. Salivary flow-rate and composition was examined in 17 patients who agreed to participate and in a matched group of healthy controls. No significant differences were detected in composition or flow-rates of resting and stimulated saliva. The salivary flow-rates in the schizophrenic patients on clozapine did not correlate with the subjective complaint of hypersalivation. Because the severity and prevalence of the complaint was higher at night, a possibility of an altered circadian rhythm of salivation might be suggested in these patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162206     DOI: 10.1016/0006-3223(95)00296-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

Review 1.  Clozapine-induced sialorrhea: pathophysiology and management strategies.

Authors:  Samir Kumar Praharaj; Manu Arora; Sachin Gandotra
Journal:  Psychopharmacology (Berl)       Date:  2006-03-03       Impact factor: 4.530

Review 2.  Pharmacological interventions for clozapine-induced hypersalivation.

Authors:  Rebecca Syed; Katie Au; Caroline Cahill; Lorna Duggan; Yanling He; Victor Udu; Jun Xia
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

3.  Clozapine-induced hypersalivation: an estimate of prevalence, severity and impact on quality of life.

Authors:  Senan Maher; Aoife Cunningham; Niamh O'Callaghan; Fintan Byrne; Colm Mc Donald; Shane McInerney; Brian Hallahan
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-30

4.  Sialorrhea and aspiration pneumonia: a case study.

Authors:  Eileen Trigoboff; Jeffery Grace; Herman Szymanski; Jaspinder Bhullar; Claudia Lee; Thomas Watson
Journal:  Innov Clin Neurosci       Date:  2013-05

5.  Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.

Authors:  Shih-Yu Chen; Gopi Ravindran; Qichen Zhang; Steve Kisely; Dan Siskind
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

6.  Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase.

Authors:  Cyndie K Mannesse; Eugène P van Puijenbroek; Paul A F Jansen; Rob J van Marum; Patrick C Souverein; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

7.  A comprehensive salivary analysis for oral cancer diagnosis.

Authors:  Thomas Shpitzer; Gideon Bahar; Raphael Feinmesser; Rafael M Nagler
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

Review 8.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

9.  Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Authors:  Susanne Steinlechner; Christine Klein; Andreas Moser; Rebekka Lencer; Johann Hagenah
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

10.  A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.

Authors:  Vyasa Immadisetty; Pradeep Agrawal
Journal:  Ther Adv Psychopharmacol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.